19th April 2011
Patients with eye problems which are not treatable through laser eye surgery or cataract surgery could be helped by a low-cost molecular medicine, according to ophthalmologists.
Experience has shown that if patients are given this treatment when all other therapies have been discounted can offer hope for declining sight.
Speaking at the 4th Annual Nutrition and Eye conference Dr Stuart Richer said: "These nutritional molecules have begun to be rigorously studied around the world in cardiology, cancer research and some human studies, and if scientifically proven, this approach has obvious advantages when used alone or in conjunction with injected stem cells or organ transplant."
The molecular medicine can help activate the molecular properties of the eye and improve conditions such as macular degeneration and other age-related problems.
He has now suggested that opticians should stock the molecular medicine, as it can be used to improve a variety of conditions.
Up to one in five people over the age of 80 in developed countries is affected by macular degeneration which is the most common cause of blindness in the UK.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.